Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Medicare Demonstration Projects

2025 HCPCS code G9073

Invasive female breast cancer, predominantly adenocarcinoma, Stage IIIA-IIIB (not T3, N1, M0), ER/PR positive, no progression/recurrence/metastasis, not ductal carcinoma in situ.

2025 HCPCS code G9070

Reports information on a patient's small cell lung cancer disease status (extent unknown, staging in progress, or not listed) for a Medicare demonstration project.

2025 HCPCS code G9112

This HCPCS code reports information on head and neck cancer status, including staging, for a specific Medicare demonstration project in 2006.

2025 HCPCS code G9083

Reports the disease status of a patient's prostate cancer, limited to adenocarcinoma, where the extent of the disease is unknown, staging is in progress, or not listed in the record; used in a Medicare-approved demonstration project.

2025 HCPCS code G9075

Reports information on the disease status of a patient's invasive female breast cancer (adenocarcinoma, M1 stage at diagnosis, metastatic, locally recurrent, or progressive; excludes ductal carcinoma origin).

2025 HCPCS code G9050

This HCPCS code reports the primary focus of an evaluation and management (E/M) visit for a cancer patient, including work-up, evaluation, or staging at diagnosis or recurrence.

2025 HCPCS code G9077

Reports information on prostate cancer disease status for a Medicare-approved demonstration project.

2025 HCPCS code G9058

Reports that patient management differs from practice guidelines due to provider disagreement with recommendations; used in a Medicare demonstration project.

2025 HCPCS code G9078

Reports disease status of prostate cancer (limited to adenocarcinoma, T2 or T3a, Gleason 8-10, or PSA >20 at diagnosis) within a Medicare-approved demonstration project.

2025 HCPCS code G9096

Reports information on the disease status of a patient's esophageal cancer, specifically adenocarcinoma or squamous cell carcinoma, staged T1-T3, N0-N1 or NX, before neoadjuvant therapy, with no evidence of progression, recurrence, or metastasis (Medicare demonstration project).

2025 HCPCS code G9088

Oncology - other

2025 HCPCS code G9080

Oncology - Other

2025 HCPCS code G9084

Oncology - other. Current Disease Status of Oncology, Colon Cancer, Limited to Invasive, Adenocarcinoma Predominant, T1-T3, N0, M0, No Evidence of Progression, Recurrence or Metastases.

2025 HCPCS code G9072

Oncology - other

2025 HCPCS code G9132

Oncology - Other

2025 HCPCS code G9104

Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed.

2025 HCPCS code G9136

Disease status of non-Hodgkin’s lymphoma with transformation of cell type from one classification to another (Used in a Medicare demonstration project in 2006).

2025 HCPCS code G9093

Rectal cancer, limited to invasive, predominantly adenocarcinoma, initial extent of disease T4, any N, M0, before neoadjuvant therapy, no evidence of progression, recurrence, or metastases.

2025 HCPCS code G9102

Oncology; disease status; gastric cancer, limited to adenocarcinoma, clinical or pathologic M0, unresectable with no evidence of disease progression (for use in a Medicare-approved demonstration project).

2025 HCPCS code G9126

Chronic Myelogenous Leukemia, positive for Philadelphia chromosome or BCR/ABL gene, in remission.

2025 HCPCS code G9061

Available practice guidelines do not address the patient's specific cancer condition.

2025 HCPCS code G9109

Disease status of head and neck cancer, limited to cancers of the oral cavity, pharynx, and larynx with squamous cell as the predominant cell type, showing no disease progression.

2025 HCPCS code G9069

Oncology - disease status; small cell lung cancer (limited to small cell and combined small cell/non-small cell); extensive stage at diagnosis, metastatic, locally recurrent, or progressive. For use in a Medicare-approved demonstration project.

2025 HCPCS code G9094

Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a Medicare-approved demonstration project).

2025 HCPCS code G9060

Oncology - Management Differs From Practice Guidelines.

2025 HCPCS code G9016

Smoking cessation counseling, individual, per session (6-10 minutes), used in Medicare demonstration projects.

2025 HCPCS code G9092

Oncology - Rectal Cancer, Limited to Invasive, Predominantly Adenocarcinoma, T1-T3, N1-N2, M0, Pre-Neoadjuvant Therapy, No Evidence of Progression/Recurrence/Metastases

2025 HCPCS code G9131

Oncology - Other

2025 HCPCS code G9130

Oncology - Other

2025 HCPCS code G9129

Oncology - Other (Medicare demonstration project, 2006)

2025 HCPCS code G9089

Oncology - disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or extent not listed in patient record.

2025 HCPCS code G9103

Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic M1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a Medicare-approved demonstration project).

2025 HCPCS code G9133

G9133 reports the disease status of hormone-responsive prostate adenocarcinoma with metastases, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9067

Reports the disease status for non-small cell lung cancer when the extent is unknown, staging is in progress, or not listed; used within a specific Medicare demonstration project.

2025 HCPCS code G9087

Reporting code for a Medicare demonstration project, indicating a patient's colon cancer status (invasive adenocarcinoma, M1 metastasis, progressive disease).

2025 HCPCS code G9086

Reports information on a patient's colon cancer disease status: limited invasive adenocarcinoma (T1-T4, N1-N2, M0), with no evidence of progression, recurrence, or metastasis; used within a specific Medicare demonstration project.

2025 HCPCS code G9091

Reports information on the disease status of a patient's rectal cancer (predominantly adenocarcinoma, T3N0M0 stage before neoadjuvant therapy) within a specific Medicare demonstration project.

2025 HCPCS code G9059

Indicates that a cancer patient's management differs from practice guidelines due to their choice of alternative treatment or no treatment after guideline-consistent treatment was offered.

2025 HCPCS code G9115

Provides information on the disease status of epithelial ovarian cancer, for use in a 2006 Medicare demonstration project.

2025 HCPCS code G9140

Covers a stay of four or more hours in a CMS-approved Frontier Extended Stay Clinic (FESC) for seriously ill patients unable to transfer to an acute care hospital due to extenuating circumstances.

2025 HCPCS code G9109

头颈部癌的疾病状态，仅限于以鳞状细胞为主要细胞类型的口腔癌、咽癌和喉癌，未显示疾病进展。

2025 HCPCS code G9107

肿瘤学-其他

2025 HCPCS code G9084

Oncología: otra. Estado actual de la oncología: cáncer de colon, limitado a invasivo, con predominio del adenocarcinoma, T1-T3, N0, M0, no hay evidencia de progresión, recurrencia o metástasis.

2025 HCPCS code G9135

Oncology; Disease status; Non-Hodgkin’s lymphoma, any cellular classification; Stage III, IV, not relapsed, not refractory.

2025 HCPCS code G9101

Provides information on the disease status of gastric adenocarcinoma, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9100

Provides information about the disease status of gastric adenocarcinoma, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9053

This HCPCS code reports the primary focus of an evaluation and management (E/M) visit for a cancer patient undergoing expectant management, where no cancer-directed therapy is administered.

2025 HCPCS code G9055

This HCPCS code reports the primary focus of a cancer patient's visit when another unspecified service is rendered, not listed in other HCPCS codes.It's part of a Medicare demonstration project.

2025 HCPCS code G9113

Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage IA-B (grade 1) without recurrence or progression.

2025 HCPCS code G9097

This code reports information on the disease status of esophageal cancer (adenocarcinoma or squamous cell carcinoma), used in a 2006 Medicare demonstration project.